Investigating Enhanced Weight Loss: Tirzepatide Plus Mibavademab Combination for Obesity
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Abstract
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of Once-Weekly Tirzepatide Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
NCT ID: NCT06373146
Status: ACTIVE_NOT_RECRUITIN…